Antengene Bags Thailand FDA Approval To commercialize Xpovio

Antengene Corporation Limited, a top creative, internationally-operating biopharmaceutical company focused on finding, creating, and selling top-of-the-line medications for cancer, revealed that the Thailand Food and Drug Administration has given...

Govt Explores random testing of imported Medical Devices

The government is considering overseeing the quality of imported medical devices through a risk-based method in which random samples will be selected for quality testing, with entire shipments of critical diagnostic kits being...

CD Biopharma Receives US FDA Nod to commence phase I trial

Suzhou-based CD Biopharma, a fast-growing biotech company in the clinical stage, has been approved by the FDA for its CD-001 Investigational New Drug (IND) application, marking the start of a phase I human trial...

US FDA Nods AstraZeneca's Nasal Spray for Self Administration

AstraZeneca, a worldwide biopharmaceutical company focused on science, declared that FluMist is now the sole self-administered flu vaccine approved in the United States. FluMist, a nasal spray without needles, was authorized for...

PM Modi pledges $7.5 Mn to Quad Cancer Moonshot to battle cervical cancer

Prime Minister Narendra Modi declared assistance of USD 7.5 million in sampling kits, detection kits, and vaccines for nations combatting cervical cancer. Addressing the Cancer Moonshot event in Delaware, Modi stressed India's dedication to...

InnoCare Pharma Bags Chinese nod to begin clinical trial of BCL2 inhibitor

InnoCare Pharma, a top biopharmaceutical company specializing in cancer and autoimmune disease treatments, declared the approval of the Investigational New Drug (IND) to carry out a clinical trial of ICP-248, a B-cell lymphoma-2 (BCL2) inhibitor...

BFI and BIRAC ink a Letter of Intent to advance biomedical innovation

Blockchain for Impact (BFI), a philanthropic organisation, has signed a Letter of Intent to collaborate with the Biotechnology Industry Research Assistance Council (BIRAC), Department of Biotechnology, Government of India, marking a significant...

Lupin Forays into non-exclusive patent licensing agreement with Takeda

Leading pharmaceutical company Lupin Limited has revealed a non-exclusive patent license agreement with Takeda Pharmaceutical Company Limited to sell vonoprazan tablets in India. Lupin will be launching their new drug, Lupivon, in two different...

Zydus Lifesciences to acquire Sterling Biotech's API biz for Rs 84 crore

Zydus Lifesciences Ltd announced that it will acquire Sterling Biotech's 'Target Business', which is principally engaged in the manufacturing process of fermentation-based active pharmaceutical ingredients products, as well as a production facility..

ORDI & St John's Medical College Team Up to Support Kidney Disease Patients

The Organisation for Rare illnesses India (ORDI) and St John's Medical College and Hospital have signed a Memorandum of Understanding (MoU) to help children with rare kidney illnesses and their families. These include about 150 rare illnesses...

on the deck


Most Viewed

Editor's Guest


© 2025 India Pharma Outlook. All Rights Reserved.